120 related articles for article (PubMed ID: 1647796)
1. Cytochemically detectable glucose-6-phosphate dehydrogenase-stimulating/Na-K-ATPase-inhibiting activity of plasma and hypothalamus in reduced renal mass hypertension.
Holland S; Millett J; Alaghband-Zadeh J; de Wardener H; Pamnani M; Haddy F
Am J Hypertens; 1991 Apr; 4(4 Pt 1):315-20. PubMed ID: 1647796
[TBL] [Abstract][Full Text] [Related]
2. Na-K-ATPase-inhibiting and glucose-6-phosphate dehydrogenase-stimulating activity of plasma and hypothalamus of the Okamoto spontaneously hypertensive rat.
Millett JA; Holland SM; Alaghband-Zadeh J; de Wardener HE
J Endocrinol; 1986 Jan; 108(1):69-73. PubMed ID: 3003223
[TBL] [Abstract][Full Text] [Related]
3. Extraction and characterization of a cytochemically assayable Na+/K+-ATPase inhibitor/glucose-6-phosphate dehydrogenase stimulator in the hypothalamus and plasma of man and the rat.
Millett JA; Holland SM; Alaghband-Zadeh J; de Wardener HE
J Endocrinol; 1987 Feb; 112(2):299-303. PubMed ID: 3029264
[TBL] [Abstract][Full Text] [Related]
4. Ouabainlike Na+,K+-ATPase inhibitor in the plasma of normotensive and hypertensive humans and rats.
de Wardener HE; Millett J; Holland S; MacGregor GA; Alaghband-Zadeh J
Hypertension; 1987 Nov; 10(5 Pt 2):I52-6. PubMed ID: 2824366
[TBL] [Abstract][Full Text] [Related]
5. [Cytochemical demonstration of an endogenous inhibitor of Na-K ATPase and its relationship to familial arterial hypertension].
de Wardener H
Nephrologie; 1987; 8(1):3-6. PubMed ID: 3035398
[TBL] [Abstract][Full Text] [Related]
6. Cytochemically assayable Na+,K+-ATPase inhibition by Milan hypertensive rat plasma.
Holland S; Millett J; Alaghband-Zadeh J; de Wardener H; Ferrari P; Bianchi G
Hypertension; 1987 May; 9(5):498-503. PubMed ID: 3032790
[TBL] [Abstract][Full Text] [Related]
7. Evidence that the hypothalamus may be a source of a circulating Na+-K+-ATPase inhibitor.
Alaghband-Zadeh J; Fenton S; Hancock K; Millett J; de Wardener HE
J Endocrinol; 1983 Aug; 98(2):221-6. PubMed ID: 6308123
[TBL] [Abstract][Full Text] [Related]
8. Effect of hemicholinium-3 on the hypothalamic concentration of a cytochemically detectable glucose-6-phosphate dehydrogenase-stimulating substance.
Vargas HM; Brezenoff HE; Morris HR; Panico M; Etienne A; Challand GS; Holland SM; Alaghband Zadeh J; de Wardener HE
J Cardiovasc Pharmacol; 1994 Nov; 24(5):773-8. PubMed ID: 7532755
[TBL] [Abstract][Full Text] [Related]
9. The endogenous cytochemically assayable Na-K-ATPase inhibitor and its relation to hypertension.
de Wardener HE; Millet J; Holland S; MacGregor G; Alaghband-Zadeh J
Klin Wochenschr; 1987; 65 Suppl 8():4-7. PubMed ID: 3599801
[TBL] [Abstract][Full Text] [Related]
10. An increase in a circulating inhibitor of Na+,K+-dependent ATPase: a possible link between salt intake and the development of essential hypertension.
MacGregor GA; Fenton S; Alaghband-Zadeh J; Markandu ND; Roulston JE; de Wardener HE
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():17s-20s. PubMed ID: 6274566
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertension.
MacGregor GA; Fenton S; Alaghband-Zadeh J; Markandu N; Roulston JE; de Wardener HE
Br Med J (Clin Res Ed); 1981 Nov; 283(6303):1355-7. PubMed ID: 6274473
[TBL] [Abstract][Full Text] [Related]
12. The relation of the natriuretic hormone to essential hypertension.
de Wardener HE; MacGregor GA
Postgrad Med J; 1983; 59 Suppl 2():74-7. PubMed ID: 6310538
[TBL] [Abstract][Full Text] [Related]
13. Myocardial Na, K-ATPase in one-kidney, one-clip hypertensive rats.
Whitmer KR; Lee JH; Martin AF; Lane LK; Lee SW; Schwartz A; Overbeck HW; Wallick ET
J Mol Cell Cardiol; 1986 Oct; 18(10):1085-95. PubMed ID: 3023643
[TBL] [Abstract][Full Text] [Related]
14. Decreased myocardial Na+K+ATPase activity in rats with reduced renal mass-saline hypertension.
Clough DL; Huot SJ; Pamnani MB; Haddy FJ
J Hypertens; 1985 Dec; 3(6):583-9. PubMed ID: 3003189
[TBL] [Abstract][Full Text] [Related]
15. Ouabainlike factor in Milan hypertensive rats.
Ferrandi M; Minotti E; Salardi S; Florio M; Bianchi G; Ferrari P
Am J Physiol; 1992 Oct; 263(4 Pt 2):F739-48. PubMed ID: 1329560
[TBL] [Abstract][Full Text] [Related]
16. [Na,K-ATPase from the outer kidney medulla of spontaneously hypertensive rats in ontogenesis].
Boldyrev AA; Orlov SN; Svinukhova IA; Stetsiuk NU
Vopr Med Khim; 1987; 33(4):56-9. PubMed ID: 2821696
[TBL] [Abstract][Full Text] [Related]
17. An active sodium transport inhibitor released from spontaneously hypertensive and normotensive rat fetal hypothalamic cells in culture.
Kendall JM; Thomas SE; Spurlock G; Mir MA
Am J Hypertens; 1988 Jul; 1(3 Pt 3):83S-87S. PubMed ID: 2843202
[TBL] [Abstract][Full Text] [Related]
18. Decreased myocardial Na+-K+-ATPase activity in one-kidney, one-clip hypertensive rats.
Clough DL; Pamnani MB; Haddy FJ
Am J Physiol; 1983 Aug; 245(2):H244-51. PubMed ID: 6136190
[TBL] [Abstract][Full Text] [Related]
19. Rat hypothalamic extract inhibits vasopressin-stimulated Na+-K+-ATPase activity in the rat renal medulla.
Pippard C; Baylis PH
Cell Biochem Funct; 1986 Jan; 4(1):25-9. PubMed ID: 3002655
[TBL] [Abstract][Full Text] [Related]
20. Altered arachidonic acid metabolism contributes to the failure of dopamine to inhibit Na+,K(+)-ATPase in kidney of spontaneously hypertensive rats.
Hussain T; Lokhandwala MF
Clin Exp Hypertens; 1996 Oct; 18(7):963-74. PubMed ID: 8886479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
